+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ADVENZYMES

Advanced Enzyme Technologies Share Price

₹263.55 -0.6 (-0.23%)
New 52W Low in past week

30 Oct, 2026 3:31 PM (IST)

Advanced Enzyme Technologies live price: ₹263.55. It opened at ₹266 vs previous close ₹264; intraday high/low: ₹268/₹260. The 50 & 200 DMA stand at ₹280.70/₹306.50.

Advanced Enzyme Technologies Performance

  • Today's Low
  • ₹260
  • Today's High
  • ₹268
  • 52 Week Low
  • ₹247
  • 52 Week High
  • ₹419
  • Open Price₹266
  • Previous Close₹264
  • Volume188,196
  • 50 DMA₹280.70
  • 100 DMA₹295.60
  • 200 DMA₹306.50

Advanced Enzyme Technologies Chart

Investment Returns

  • Over 1 Month -6.41%
  • Over 3 Month -16.36%
  • Over 6 Month -24.2%
  • Over 1 Year -14.45%

Smart Investing Starts Here Start SIP with Advanced Enzyme Technologies for Steady Growth!

Invest Now

Advanced Enzyme Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 17.3
  • PEG Ratio
  • 1.1
  • Market Cap Cr
  • 2,951
  • P/B Ratio
  • 1.8
  • Average True Range
  • 8.9
  • EPS
  • 15.3
  • Dividend Yield
  • 0.5
  • MACD Signal
  • -7
  • RSI
  • 43.21
  • MFI
  • 49.52

Latest Stock News Updates

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Post Buyback Public Announcement

Please find enclosed herewith Post Buyback Public Announcement.

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Investor Presentation

Please find enclosed herewith Earnings Presentation for quarter and half year ended September 30, 2026.

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed herewith press release titled Quarterly Earnings Release dated October 31, 2026.

Advanced Enzyme Technologies Financials

Advanced Enzyme Technologies Technicals

EMA & SMA

Current Price
₹263.55
-0.6 (-0.23%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹265.90
  • 50 Day
  • ₹280.70
  • 100 Day
  • ₹295.60
  • 200 Day
  • ₹306.50

Resistance and Support

263.68 Pivot Speed
  • R3 276.40
  • R2 272.20
  • R1 267.90
  • S1 259.40
  • S2 255.20
  • S3 250.80

Advanced Enzyme Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-31 Quarterly Results
2026-08-08 Quarterly Results & Buy Back
2026-05-09 Audited Results & Dividend
2026-01-31 Quarterly Results
2025-11-12 Quarterly Results
Date Purpose Remarks
2026-07-24 FINAL Rs.1.35 per share(67.5%)Dividend
2025-07-23 FINAL Rs.1.20 per share(60%)Final Dividend
2025-05-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
2024-07-18 FINAL Rs.1.10 per share(55%)Final Dividend
2024-05-18 INTERIM Rs.4.00 per share(200%)Interim Dividend
View Advanced Enzyme Technologies Dividend History Arrow
Date Purpose Remarks
2017-05-26 Split

Advanced Enzyme Technologies Shareholding Pattern

43.56%
27.9%
26.64%
1.18%
0.71%

About Advanced Enzyme Technologies

Advanced Enzyme Techs. engaged in the business of manufacturing and sales of enzymes. View More
  • NSE Symbol
  • ADVENZYMES
  • BSE Symbol
  • 540025
  • Managing Director,Head(Business Development)
  • Ms. Martina Doering
  • ISIN
  • INE837H01020

Similar Stocks to Advanced Enzyme Technologies

Advanced Enzyme Technologies FAQs

Advanced Enzyme Technologies share price is ₹263 As on 01 November, 2026 | 09:51

The Market Cap of Advanced Enzyme Technologies is ₹2951.1 Cr As on 01 November, 2026 | 09:51

The P/E ratio of Advanced Enzyme Technologies is 17.3 As on 01 November, 2026 | 09:51

The PB ratio of Advanced Enzyme Technologies is 1.8 As on 01 November, 2026 | 09:51

The 52 week High & Low of Advanced Enzyme Technologies is ₹419/₹246.8 respectively As on 01 November, 2026 | 09:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23